Study of the Relationship Between Sleep Quality and Daytime-Nighttime Variations of Blood Pressure and Plasma Glucose Type I

NCT00805974 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2009-01-14

No results posted yet for this study

Summary

The primary objectives are to compare the mean levels of the sleep quality parameters of subjects : with a nocturnal fall of the SBP (Systolic blood pressure), DBP (diastolic blood pressure) and MAP (mean arterial pressure) over of egal to 10% (dipping subjects) and of subjects with a nocturnal fall of SBP, DBP and MAP inferior to 10% (non dipper subjects).

The secondary objectives are :

Establish correlations between:

* The quality of sleep parameters
* The parameters of BP variations between the diurnal and nocturnal periods and the awake periods of sleep defined in reference to polysomnography.
* The glycemia levels on 24h with a glycemic holter. The parameters of the sympathic system activation evaluated in reference to the measure of the baroreflex sensibility during the awake period.

Conditions

Interventions

BIOLOGICAL

Biological examinations (blood and urinary).

Sponsors & Collaborators

  • Pr Mallion Jean-Michel

    collaborator UNKNOWN
  • Pr BAGUET Jean-Philippe

    collaborator UNKNOWN
  • Pr BENHAMOU Pierre-Yves

    collaborator UNKNOWN
  • Pr LEVY Patrick

    collaborator UNKNOWN
  • Dr MOURET Sandrine

    collaborator UNKNOWN
  • Dr ORMEZZANO Olivier

    collaborator UNKNOWN
  • Pr PEPIN Jean-Louis

    collaborator UNKNOWN
  • Dr TAMISIER Renaud

    collaborator UNKNOWN
  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • MALLION Jean-Michel, Pr · University Hospital, Grenoble

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00805974 on ClinicalTrials.gov